Search by Drug Name or NDC

    NDC 51862-0606-50 Halobetasol propionate 0.5 mg/g Details

    Halobetasol propionate 0.5 mg/g

    Halobetasol propionate is a TOPICAL AEROSOL, FOAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mayne Pharma. The primary component is HALOBETASOL PROPIONATE.

    Product Information

    NDC 51862-0606
    Product ID 51862-606_f7af4186-fdc8-41b9-898a-f18ab831eb04
    Associated GPIs 90550073103920
    GCN Sequence Number 079214
    GCN Sequence Number Description halobetasol propionate FOAM 0.05 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 45667
    HICL Sequence Number 006037
    HICL Sequence Number Description HALOBETASOL PROPIONATE
    Brand/Generic Generic
    Proprietary Name Halobetasol propionate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Halobetasol propionate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form AEROSOL, FOAM
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name HALOBETASOL PROPIONATE
    Labeler Name Mayne Pharma
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA210566
    Listing Certified Through 2024-12-31

    Package

    NDC 51862-0606-50 (51862060650)

    NDC Package Code 51862-606-50
    Billing NDC 51862060650
    Package 1 CANISTER in 1 CARTON (51862-606-50) / 50 g in 1 CANISTER
    Marketing Start Date 2019-02-04
    NDC Exclude Flag N
    Pricing Information N/A